Bioequivalence Study of Two Oral Nitisinone Formulations to Treat Hereditary Tyrosinemia (HT-1)

NCT02750345 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Tyrosinemia, Type I

Interventions

DRUG: Nitisinone
DRUG: Nitisinone Baked Tablet
DRUG: Orfadin

Sponsor

Cycle Pharmaceuticals Ltd.

Collaborators

[object Object]